Qingdao Haier Biomedical Co Ltd
SSE:688139

Watchlist Manager
Qingdao Haier Biomedical Co Ltd Logo
Qingdao Haier Biomedical Co Ltd
SSE:688139
Watchlist
Price: 35.69 CNY -2.96% Market Closed
Market Cap: 11.3B CNY
Have any thoughts about
Qingdao Haier Biomedical Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Qingdao Haier Biomedical Co Ltd stock under the Base Case scenario is 59.02 CNY. Compared to the current market price of 35.69 CNY, Qingdao Haier Biomedical Co Ltd is Undervalued by 40%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
59.02 CNY
Undervaluation 40%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Qingdao Haier Biomedical Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Qingdao Haier Biomedical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Qingdao Haier Biomedical Co Ltd?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Health Care Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Qingdao Haier Biomedical Co Ltd

Provide an overview of the primary business activities
of Qingdao Haier Biomedical Co Ltd.

What unique competitive advantages
does Qingdao Haier Biomedical Co Ltd hold over its rivals?

What risks and challenges
does Qingdao Haier Biomedical Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Qingdao Haier Biomedical Co Ltd.

Provide P/S
for Qingdao Haier Biomedical Co Ltd.

Provide P/E
for Qingdao Haier Biomedical Co Ltd.

Provide P/OCF
for Qingdao Haier Biomedical Co Ltd.

Provide P/FCFE
for Qingdao Haier Biomedical Co Ltd.

Provide P/B
for Qingdao Haier Biomedical Co Ltd.

Provide EV/S
for Qingdao Haier Biomedical Co Ltd.

Provide EV/GP
for Qingdao Haier Biomedical Co Ltd.

Provide EV/EBITDA
for Qingdao Haier Biomedical Co Ltd.

Provide EV/EBIT
for Qingdao Haier Biomedical Co Ltd.

Provide EV/OCF
for Qingdao Haier Biomedical Co Ltd.

Provide EV/FCFF
for Qingdao Haier Biomedical Co Ltd.

Provide EV/IC
for Qingdao Haier Biomedical Co Ltd.

Show me price targets
for Qingdao Haier Biomedical Co Ltd made by professional analysts.

What are the Revenue projections
for Qingdao Haier Biomedical Co Ltd?

How accurate were the past Revenue estimates
for Qingdao Haier Biomedical Co Ltd?

What are the Net Income projections
for Qingdao Haier Biomedical Co Ltd?

How accurate were the past Net Income estimates
for Qingdao Haier Biomedical Co Ltd?

What are the EPS projections
for Qingdao Haier Biomedical Co Ltd?

How accurate were the past EPS estimates
for Qingdao Haier Biomedical Co Ltd?

What are the EBIT projections
for Qingdao Haier Biomedical Co Ltd?

How accurate were the past EBIT estimates
for Qingdao Haier Biomedical Co Ltd?

Compare the revenue forecasts
for Qingdao Haier Biomedical Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Qingdao Haier Biomedical Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Qingdao Haier Biomedical Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Qingdao Haier Biomedical Co Ltd compared to its peers.

Compare the P/E ratios
of Qingdao Haier Biomedical Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Qingdao Haier Biomedical Co Ltd with its peers.

Analyze the financial leverage
of Qingdao Haier Biomedical Co Ltd compared to its main competitors.

Show all profitability ratios
for Qingdao Haier Biomedical Co Ltd.

Provide ROE
for Qingdao Haier Biomedical Co Ltd.

Provide ROA
for Qingdao Haier Biomedical Co Ltd.

Provide ROIC
for Qingdao Haier Biomedical Co Ltd.

Provide ROCE
for Qingdao Haier Biomedical Co Ltd.

Provide Gross Margin
for Qingdao Haier Biomedical Co Ltd.

Provide Operating Margin
for Qingdao Haier Biomedical Co Ltd.

Provide Net Margin
for Qingdao Haier Biomedical Co Ltd.

Provide FCF Margin
for Qingdao Haier Biomedical Co Ltd.

Show all solvency ratios
for Qingdao Haier Biomedical Co Ltd.

Provide D/E Ratio
for Qingdao Haier Biomedical Co Ltd.

Provide D/A Ratio
for Qingdao Haier Biomedical Co Ltd.

Provide Interest Coverage Ratio
for Qingdao Haier Biomedical Co Ltd.

Provide Altman Z-Score Ratio
for Qingdao Haier Biomedical Co Ltd.

Provide Quick Ratio
for Qingdao Haier Biomedical Co Ltd.

Provide Current Ratio
for Qingdao Haier Biomedical Co Ltd.

Provide Cash Ratio
for Qingdao Haier Biomedical Co Ltd.

What is the historical Revenue growth
over the last 5 years for Qingdao Haier Biomedical Co Ltd?

What is the historical Net Income growth
over the last 5 years for Qingdao Haier Biomedical Co Ltd?

What is the current Free Cash Flow
of Qingdao Haier Biomedical Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Qingdao Haier Biomedical Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Qingdao Haier Biomedical Co Ltd

Current Assets 2.4B
Cash & Short-Term Investments 1.7B
Receivables 434m
Other Current Assets 276.5m
Non-Current Assets 3.2B
Long-Term Investments 1B
PP&E 914.5m
Intangibles 1.2B
Other Non-Current Assets 69.4m
Current Liabilities 936.6m
Accounts Payable 312.8m
Accrued Liabilities 92.8m
Short-Term Debt 131.6m
Other Current Liabilities 399.4m
Non-Current Liabilities 395.8m
Long-Term Debt 7.6m
Other Non-Current Liabilities 388.2m
Efficiency

Earnings Waterfall
Qingdao Haier Biomedical Co Ltd

Revenue
2.2B CNY
Cost of Revenue
-1.2B CNY
Gross Profit
1.1B CNY
Operating Expenses
-762.5m CNY
Operating Income
306m CNY
Other Expenses
56m CNY
Net Income
362m CNY

Free Cash Flow Analysis
Qingdao Haier Biomedical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Qingdao Haier Biomedical Co Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Year Average ROIC
Positive Net Income
57/100
Profitability
Score

Qingdao Haier Biomedical Co Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Qingdao Haier Biomedical Co Ltd's solvency score is 84/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Negative Net Debt
Low D/E
84/100
Solvency
Score

Qingdao Haier Biomedical Co Ltd's solvency score is 84/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Qingdao Haier Biomedical Co Ltd

Wall Street analysts forecast Qingdao Haier Biomedical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Qingdao Haier Biomedical Co Ltd is 81.6 CNY with a low forecast of 80.8 CNY and a high forecast of 84 CNY.

Lowest
Price Target
80.8 CNY
126% Upside
Average
Price Target
81.6 CNY
129% Upside
Highest
Price Target
84 CNY
135% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Qingdao Haier Biomedical Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Qingdao Haier Biomedical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Qingdao Haier Biomedical Co Ltd Logo
Qingdao Haier Biomedical Co Ltd

Country

China

Industry

Health Care

Market Cap

11.3B CNY

Dividend Yield

0%

Description

Qingdao Haier Biomedical Co., Ltd. engages in the development of biotech products. The company is headquartered in Qingdao, Shandong and currently employs 2,078 full-time employees. The company went IPO on 2019-10-25. The firm's main businesses include: providing biomedical low-temperature storage solutions covering the whole temperature range for scenarios such as sample safety, drug and reagent safety, vaccine safety and blood safety, as well as automatic, intelligent and comprehensive upgrading based on user needs, and providing integrated solutions for Internet of Thing (IoT) scenarios covering a variety of biosafety products. The firm's products are sold to domestic and overseas markets.

Contact

SHANDONG
Qingdao
Haier Biomedical Emerging Industrial Park, No. 280 Fengyuan Road, High-tech Zone
+8653288935566
www.haierbiomedical.com

IPO

2019-10-25

Employees

2 078

Officers

GM & Director
Dr. Zhanjie Liu
Chief Financial Officer
Ms. Ruijuan Mo
Deputy GM & Director
Mr. Wenfu Wang
Board Secretary
Ms. Yanli Huang
Deputy General Manager
Ms. Ji Zhang
International Human Resources Director
Ms. Shirley Zhang
Show More
Chief Engineer
Mr. Jiangtao Zhang
Show Less

See Also

Discover More
What is the Intrinsic Value of one Qingdao Haier Biomedical Co Ltd stock?

The intrinsic value of one Qingdao Haier Biomedical Co Ltd stock under the Base Case scenario is 59.02 CNY.

Is Qingdao Haier Biomedical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 35.69 CNY, Qingdao Haier Biomedical Co Ltd is Undervalued by 40%.

Back to Top